Pegylated interferon and ribavirin treatment for chronic hepatitis C deteriorates subclinical markers of vascular function
| Autor: | Ageliki Laina, Kimon Stamatelopoulos, Christos Kontogiannis, Larisa Vasilieva, Spyridon P. Dourakis, Alexandra Alexopoulou, D Bampatsias, Iliana Mani, Georgios Georgiopoulos, Sophia Pouriki, Dimitrios Tousoulis |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male medicine.medical_specialty MEDLINE Blood Pressure Hepacivirus Pulse Wave Analysis Antiviral Agents Gastroenterology chemistry.chemical_compound Pharmacotherapy Meta-Analysis as Topic Pegylated interferon Internal medicine Ribavirin Humans Medicine Subclinical infection business.industry Case-control study Hepatitis C Hepatitis C Chronic Middle Aged Atherosclerosis medicine.disease Healthy Volunteers Treatment Outcome chemistry Cardiovascular Diseases Case-Control Studies Drug Therapy Combination Female Interferons Cardiology and Cardiovascular Medicine business Vascular function medicine.drug |
| Zdroj: | Hellenic Journal of Cardiology. 60:143-145 |
| ISSN: | 1109-9666 |
| DOI: | 10.1016/j.hjc.2018.07.001 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|